Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3 Colonic Neoplasms 3 Sarcopenia 2 Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Stomach Neoplasms 1 Seaweed Associated Changes in Healthy Subjects 1 Rectal Neoplasms 1 Proctitis 1 Multiple Myeloma 1 Mucositis 1 Metabolic Syndrome 1 Malnutrition 1 Lymphoma 1 Liver Failure 1 Insulin Resistance 1 Hyperandrogenism 1 Head and Neck Neoplasms 1 Glucose Intolerance 1 Fibrosis 1 Diarrhea 1 Colonic Polyps 1 Cholangiocarcinoma 1 Chemotherapy-related Diarrhea 1 Carcinoma, Hepatocellular 1 Anovulation 1

Interventions

Blood Specimen Collection 7 Pentoxifylline 4 Liver Transplantation 4 Magnetic Resonance Spectroscopy 3 Tocopherols 2 Low-Level Light Therapy 2 High-Energy Shock Waves 2 tremelimumab 1 sonidegib 1 maltodextrin 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 apixaban 1 alpha-Tocopherol 1 Vitamin E 1 Vitamin D 1 User-Centered Design 1 Tenofovir 1 Surveys and Questionnaires 1 Sunitinib 1 Standard of Care 1 Spermine Synthase 1 Specimen Handling 1 Sorafenib 1 Sonazoid 1 Sodium Chloride 1 Sampling Studies 1 Restraint, Physical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Fibrosis × maltodextrin × Clear all

NCT03908255 2022-01-28

BCAA in HCC

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Withdrawn

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Failure, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon ⚡